Cargando…
Minimally invasive surfactant therapy versus InSurE in preterm neonates of 28 to 34 weeks with respiratory distress syndrome on non-invasive positive pressure ventilation—a randomized controlled trial
Preterm neonates with respiratory distress syndrome (RDS) are commonly treated with surfactant by intubate surfactant extubate (InSurE) technique. Mode of surfactant administration has evolved towards less invasive technique in the last few years. We randomised 58 preterm infants of 28–34 weeks of g...
Autores principales: | Gupta, Bhupendra Kumar, Saha, Anindya Kumar, Mukherjee, Suchandra, Saha, Bijan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251045/ https://www.ncbi.nlm.nih.gov/pubmed/32462483 http://dx.doi.org/10.1007/s00431-020-03682-9 |
Ejemplares similares
-
Nasal HFOV versus nasal IPPV as a post-extubation respiratory support in preterm infants—a randomised controlled trial
por: Seth, Soutrik, et al.
Publicado: (2021) -
The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25–28 weeks gestation
por: Dargaville, Peter A, et al.
Publicado: (2014) -
Less invasive surfactant administration via infant feeding tube versus InSurE method in preterm infants: a randomized control trial
por: Anand, Rohit, et al.
Publicado: (2022) -
Surfactant lung delivery with LISA and InSurE in adult rabbits with respiratory distress
por: Ricci, Francesca, et al.
Publicado: (2021) -
Less invasive surfactant administration and complications of preterm birth
por: Härtel, Christoph, et al.
Publicado: (2018)